Luis R. Feliz
Morges, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: September 01, 2022
Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma.
Journal: Targeted oncology
Published: July 29, 2022
Progression-Free Survival in Patients With Cholangiocarcinoma With or Without FGF/FGFR Alterations: A FIGHT-202 Post Hoc Analysis of Prior Systemic Therapy Response.
Journal: JCO precision oncology
Published: May 11, 2022
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 18, 2022
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling.
Journal: The Journal of molecular diagnostics : JMD
Published: June 17, 2021
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: January 19, 2021
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Journal: Future oncology (London, England)
Published: July 18, 2020
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib.
Journal: Cancer discovery
Published: June 05, 2020
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: November 26, 2019
Anti-vascular endothelial growth factor therapy in the era of personalized medicine.
Journal: Cancer chemotherapy and pharmacology
Published: November 20, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026